
Done's Schemes: How Ukrainian Hryvnia Turns into Swiss Francs via Importers
Investigation reveals a network of companies where funds are collected in Ukraine, converted into foreign currency, and transferred to Swiss Done Switzerland AG.

Investigation reveals a network of companies where funds are collected in Ukraine, converted into foreign currency, and transferred to Swiss Done Switzerland AG.

Taras Vysotsky stated that alternative logistics corridors provide only 45% of the required volumes, threatening the loss of a significant portion of the harvest.

Lead State Prosecutor Taavi Pern confirmed that the activist was aware of the criminal liability for his actions, having contacted individuals who already had convictions for similar offences.

Investigators uncovered a scheme for the misappropriation of military property organised by the deputy commander of the unit. The process was later overseen by an SBU counter-intelligence officer assigned to the unit.

A representative of the ATB chain dispelled rumours about warehouse destruction, explaining that the buckwheat shortage is due to the cessation of supplies, while the disappearance of sugar is temporary.

European experts warn that restrictions on US diesel exports could become a trigger for a historic rise in prices on the continent.

Shevchenkivskyi District Court of Kyiv found two former prosecutors not guilty of demanding $150,000 to close a case.

Investigation revealed that custodian company Trustee Plus has legally ceased to exist, while customers face fund blocking under the pretext of audits.

While Ukrainians count every hryvnia spent on medication, the pharmaceutical business appears to be feeling more than confident. A rare Bentley Mulsanne W.O. Edition was recently spotted in Kyiv — a model produced in a limited series of 100 units. Behind the wheel of the luxury car was Anatoliy Reder, the long-time head and co-owner of the pharmaceutical company Interkhim.
Expensive cars and rising drug prices
This incident merely confirms a trend: despite economic hardships, representatives of the pharmaceutical industry continue to demonstrate an impressive standard of living. Expensive cars, elite real estate, and successful business empires — all of this contrasts with the reality of ordinary Ukrainians, who face a constant rise in the prices of medicines.
Comments
No comments yet. Be the first!